{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:44:25Z","timestamp":1790318665696,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":730,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jcf.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T12:23:37Z","timestamp":1453983817000},"page":"652-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthma"],"prefix":"10.1016","volume":"15","author":[{"given":"Hagit","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Cohen-Cymberknoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8084-9052","authenticated-orcid":false,"given":"Nitai","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Hoshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Mussaffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Stafler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Kerem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1986-4349","authenticated-orcid":false,"given":"Hannah","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcf.2016.01.003_bb0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","article-title":"Inflammation in cystic fibrosis lung disease: pathogenesis and therapy","volume":"14","author":"Cantin","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.003_bb0010","first-page":"30","article-title":"Asthma in cystic fibrosis","volume":"96","author":"Balfour-Lynn","year":"2003","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jcf.2016.01.003_bb0015","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1164\/ajrccm.161.5.9903102","article-title":"Asthma. From bronchoconstriction to airways inflammation and remodelling","volume":"161","author":"Bousquet","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.003_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2213-2600(12)70058-9","article-title":"How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions: implications for airway hyper-responsiveness and asthma in cystic fibrosis","volume":"1","author":"McCuaig","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.jcf.2016.01.003_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1183\/09031936.98.12020315","article-title":"Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC)","volume":"12","author":"ISAAC Steering Committee","year":"1998","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2016.01.003_bb0030","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2016.01.003_bb0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry. Series \u201cATS\/ERS Task Force: standardisation of lung function testing\u201d","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jcf.2016.01.003_bb0040","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2016.01.003_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0272-5231(21)00618-3","article-title":"Response to bronchodilators","volume":"10","author":"Shim","year":"1989","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jcf.2016.01.003_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation consensus conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jcf.2016.01.003_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcf.2006.01.005","article-title":"Fecal elastase-1: utility in pancreatic function in cystic fibrosis","volume":"5","author":"Daftary","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2016.01.003_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1465-9921-11-140","article-title":"Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients","volume":"11","author":"Green","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2016.01.003_bb0065","first-page":"1","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.","volume":"262","author":"Hoiby","year":"1977","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"issue":"Suppl. 38","key":"10.1016\/j.jcf.2016.01.003_bb0070","first-page":"37","article-title":"Bronchodilators in cystic fibrosis","volume":"93","author":"Brand","year":"2000","journal-title":"J R Soc Med"},{"issue":"2","key":"10.1016\/j.jcf.2016.01.003_bb0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1378\/chest.94.2.360","article-title":"Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease","volume":"94","author":"Eggleston","year":"1988","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcf.2016.01.003_bb0080","first-page":"446","article-title":"Bronchial reactivity in cystic fibrosis","volume":"61","author":"Mellis","year":"1978","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jcf.2016.01.003_bb0085","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1542\/peds.90.5.703","article-title":"Wheezing in infants with cystic fibrosis: clinical course, pulmonary function, and survival analysis","volume":"90","author":"Kerem","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2016.01.003_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1164\/ajrccm\/137.1.119","article-title":"Bronchodilator responsiveness in infants and young children with cystic fibrosis","volume":"137","author":"Hiatt","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jcf.2016.01.003_bb0095","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/ajrccm\/147.3.705","article-title":"Wheezing and airflow obstruction during methacholine challenge in children with cystic fibrosis and in normal children","volume":"147","author":"Sanchez","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jcf.2016.01.003_bb0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ppul.22894","article-title":"Early childhood wheezing is associated with lower lung function in cystic fibrosis.","volume":"49","author":"Ren","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2016.01.003_bb0105","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.201004-0643OC","article-title":"Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children","volume":"182","author":"Meyerholz","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2016.01.003_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1465-9921-7-113","article-title":"Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation","volume":"7","author":"Vandebrouck","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2016.01.003_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1165\/rcmb.2006-0444OC","article-title":"Role of the cystic fibrosis transmembrane conductance channel in human airway smooth muscle","volume":"40","author":"Michoud","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.jcf.2016.01.003_bb0120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1183\/09031936.93.05091083","article-title":"Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis","volume":"5","author":"van Haren","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2016.01.003_bb0125","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1152\/jappl.1989.66.5.2124","article-title":"Heterozygotes for cystic fibrosis: models for study of airway and autonomic reactivity","volume":"66","author":"Davis","year":"1989","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jcf.2016.01.003_bb0130","first-page":"446","article-title":"Bronchial reactivity in cystic fibrosis","volume":"6","author":"Mellis","year":"1978","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jcf.2016.01.003_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/adc.51.7.507","article-title":"Association of cystic fibrosis with allergy","volume":"51","author":"Warner","year":"1976","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2016.01.003_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1099-0496(199910)28:4<248::AID-PPUL3>3.0.CO;2-N","article-title":"Investigators and coordinators of the epidemiologic study of cystic fibrosis. Patterns of medical practice in cystic fibrosis: part II. Use of therapies","volume":"28","author":"Konstan","year":"1999","journal-title":"Pediatr Pulmonol"},{"issue":"6 Suppl.","key":"10.1016\/j.jcf.2016.01.003_bb0145","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1067\/mai.2002.129704","article-title":"Effect of beta-adrenergic agonists on mucociliary clearance","volume":"110","author":"Bennett","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jcf.2016.01.003_bb0150","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1378\/chest.99.5.1088","article-title":"A controlled trial of long-term bronchodilator therapy in cystic fibrosis","volume":"99","author":"Eggleston","year":"1991","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcf.2016.01.003_bb0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1099-0496(199801)25:1<32::AID-PPUL3>3.0.CO;2-Q","article-title":"A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis","volume":"25","author":"K\u00f6nig","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2016.01.003_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ppul.1950040404","article-title":"Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathicomimetics","volume":"4","author":"Eber","year":"1988","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2016.01.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001915.pub4","article-title":"Inhaled corticosteroids for cystic fibrosis","volume":"10","author":"Balfour-Lynn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jcf.2016.01.003_bb0170","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jpeds.2008.07.010","article-title":"Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis","volume":"153","author":"Pasta","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2016.01.003_bb0175","first-page":"430S","article-title":"Effect of inhaled corticosteroids on lung function of cystic fibrosis patients \u2013 a prospective study","volume":"7","author":"Nikolaizik","year":"1994","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.jcf.2016.01.003_bb0180","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1164\/rccm.200511-1808OC","article-title":"Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis","volume":"173","author":"Balfour-Lynn","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2016.01.003_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00431-006-0198-9","article-title":"Do inhaled corticosteroids impair long term growth in prepubertal cystic fibrosis patients?","volume":"166","author":"De Boeck","year":"2007","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:11:22Z","timestamp":1692205882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199316000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1569199316000102"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2016.01.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}